Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN951608 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Coagulation Factor XII (Hageman Factor) (F12) (AA 13-43), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity Chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 13-43, N-Term
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Activated human platelets induce factor XIIa-mediated contact activation.
Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes.
Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels.
Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time.
Screening for N-glycosylated proteins by liquid chromatography mass spectrometry.
Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII.
Joseph K, Tholanikunnel TE, Kaplan AP
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2010 Jan;104(1):50-4
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2010 Jan;104(1):50-4
Activated human platelets induce factor XIIa-mediated contact activation.
Bäck J, Sanchez J, Elgue G, Ekdahl KN, Nilsson B
Biochemical and biophysical research communications 2010 Jan 1;391(1):11-7
Biochemical and biophysical research communications 2010 Jan 1;391(1):11-7
Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes.
Katakami N, Takahara M, Kaneto H, Shimizu I, Ohno K, Ishibashi F, Osonoi T, Kashiwagi A, Kawamori R, Shimomura I, Matsuhisa M, Yamasaki Y
Diabetes care 2010 Feb;33(2):390-5
Diabetes care 2010 Feb;33(2):390-5
Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels.
Calafell F, Almasy L, Sabater-Lleal M, Buil A, Mordillo C, Ramírez-Soriano A, Sikora M, Souto JC, Blangero J, Fontcuberta J, Soria JM
Human molecular genetics 2010 Feb 1;19(3):517-25
Human molecular genetics 2010 Feb 1;19(3):517-25
Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time.
Houlihan LM, Davies G, Tenesa A, Harris SE, Luciano M, Gow AJ, McGhee KA, Liewald DC, Porteous DJ, Starr JM, Lowe GD, Visscher PM, Deary IJ
American journal of human genetics 2010 Apr 9;86(4):626-31
American journal of human genetics 2010 Apr 9;86(4):626-31
Screening for N-glycosylated proteins by liquid chromatography mass spectrometry.
Bunkenborg J, Pilch BJ, Podtelejnikov AV, Wiśniewski JR
Proteomics 2004 Feb;4(2):454-65
Proteomics 2004 Feb;4(2):454-65
Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII.
Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H
The Journal of biological chemistry 2000 Oct 20;275(42):33008-13
The Journal of biological chemistry 2000 Oct 20;275(42):33008-13
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
